SK Bioscience Co. on Thursday reported its first-quarter net loss of 13.7 billion won (US$10 million), remaining in the red compared with a year ago. The company said in a regulatory filing that it continued to post an operating loss of 28.1 billion won for the January-March period, compared with a loss of 29.2 billion won a year earlier. Sales rose 8.1 percent to 22.3 billion won. Source: Yonhap News Agency
Myanmar Clears Path for Junta Leader to Become President
March 30, 2026